tiprankstipranks
Trending News
More News >
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB

Compare PharmaCyte Biotech (PMCB) vs. Competitors

Compare
261 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
PharmaCyte Biotech
$0.82
$8.30M
-0.63
-48.94%
AIM ImmunoTech
$1.25
$3.77M
-0.06
-94.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
GT Biopharma
$0.73
$7.02M
-0.15
-77.13%
1 Buy
0 Hold
0 Sell
Moderate Buy
Creative Medical Technology Holdings
$2.08
$5.21M
-0.72
-33.55%
Processa Pharmaceuticals
$0.12
$6.80M
-0.08
-83.85%
0 Buy
1 Hold
0 Sell
Hold
Tharimmune
$4.89
$193.30M
-1.40
179.59%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PMCB
PharmaCyte Biotech
0.82
-0.76
-48.16%
AIM
AIM ImmunoTech
1.21
-17.33
-93.47%
GTBP
GT Biopharma
0.51
-1.74
-77.33%
CELZ
Creative Medical Technology Holdings
2.08
-1.09
-34.38%
PCSA
Processa Pharmaceuticals
2.63
-14.43
-84.60%
THAR
Tharimmune
5.48
3.48
174.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts